N-(tert-butoxycarbonyl)-5-fluoro-2-methylindole

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: N-(tert-butoxycarbonyl)-5-fluoro-2-methylindole
• 英文别名: tert-butyl 5-fluoro-2-methyl-1H-indole-1-carboxylate；Tert-butyl 5-fluoro-2-methylindole-1-carboxylate
• 化学式: C₁₄H₁₆FNO₂
• 分子量: 249.285
• InChiKey: IWKNWCSCDJJOLV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  31.2
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-(tert-butoxycarbonyl)-5-fluoro-2-methylindole 在 三乙烯二胺 、 (S)-2-(((叔丁基二甲基甲硅烷基)氧基)二苯基甲基)吡咯烷 、 乙酸酐 、 三氟乙酸 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 0.5h， 生成 (S)-8-(4-bromophenyl)-2-fluoro-10-nitro-8,9-dihydropyrido[1,2-a]indole
  参考文献：
  名称：

  Enantioselective Construction of Dihydropyrido[1,2-a]indoles via Organocatalytic Arylmethylation of 2-Enals with Inert Aryl Methane Nucleophiles

  摘要：

  An organocatalytic asymmetric arylmethylation/N-hemiacetalization of 2-indolyl methane derivatives and 2-enals was developed. Notably, the 2-methyl of indole was readily deprotonated to produce highly reactive nucleophilic species by introducing the nitro group at the C3 position of the indole ring. A spectrum of valuable chiral dihydropyrido[1,2-a]indoles were efficiently constructed with excellent enantioselectivity (up to >99% ee). Furthermore, the corresponding products could be easily functionalized via simple deprotonation and treatment with other electrophiles with excellent diastereoselectivities (>20:1 dr).

  DOI：

  10.1021/acs.orglett.9b01837
• 作为产物：
  描述：

  5-氟-2-甲基吲哚 、 二碳酸二叔丁酯 在 4-二甲氨基吡啶 作用下， 以 乙腈 为溶剂， 反应 22.0h， 以98%的产率得到N-(tert-butoxycarbonyl)-5-fluoro-2-methylindole
  参考文献：
  名称：

  钌催化的N-boc-吲哚的不对称氢化。

  摘要：

  在适当的钌前体和反式螯合手性双膦PhTRAP生成的钌络合物存在下，成功进行了各种N-Boc-吲哚的高度对映选择性氢化。各种2-或3-取代的吲哚被转化为具有高对映体过量（至多95％ee）的手性二氢吲哚。PhTRAP-钌催化剂能够促进2，3-二甲基吲哚的氢化，得到具有72％ee的顺式2,3-二甲基二氢吲哚。

  DOI：

  10.1021/ol061039x

文献信息

• [EN] 1,3,5 -TRIAZINE-2-AMINE DERIVATIVES, PREPARATION THEREOF AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF<br/>[FR] DÉRIVÉS DE 1,3,5-TRIAZINE-2-AMINE, PROCÉDÉ DE PRÉPARATION DE CEUX-CI ET UTILISATION DIAGNOSTIQUE ET THÉRAPEUTIQUE DE CES DÉRIVÉS
  申请人：SANOFI SA

  公开号：WO2013087643A1

  公开（公告）日：2013-06-20

  The present invention relates to compounds corresponding to formula (I) in which: - R1 represents a substituted phenyl; - R2 represents: - a substituted phenyl; - a heteroaromatic group, the said group being unsubstituted or substituted one or more times; - R3 represents a group Alk; - R4 represents a hydrogen atom or a (C1-C4)alkyl; - R5 represents a hydrogen atom, a (C3-C6)cycloalkyl or a (C1-C4)alkyl-O-Alk; - or alternatively R4 and R5, together with the nitrogen atom to which they are attached, constitute a heterocyclic radical chosen from: azetidin-1-yl, pyrrolidin-1-yl, piperid-1-yl, morpholin-4-yl; - R6 represents a group -COOAlk, a group -CONH 2 or a group -NHSO 2 Alk; - Alk represents a (C1-C4)alkyl, which is unsubstituted or substituted one or more times with a halogen atom; in the form of the base or of an acid-addition salt. Preparation process and diagnostic and therapeutic use.

  本发明涉及与以下式（I）对应的化合物：- R1代表取代苯基；- R2代表：- 取代苯基；- 杂芳基团，所述基团未取代或取代一次或多次；- R3代表羟基烷基基团；- R4代表氢原子或（C1-C4）烷基；- R5代表氢原子，（C3-C6）环烷基或（C1-C4）烷基-O-烷基；- 或者R4和R5，连同它们连接的氮原子，构成从以下中选择的杂环基团：氮杂环丙烷-1-基，吡咯烷-1-基，哌啶-1-基，吗啉-4-基；- R6代表-羟基烷基基团，-酰胺基或-NHSO2烷基基团；- 烷基代表未取代或取代一次或多次的（C1-C4）烷基，其上带有卤原子；以碱或酸盐的形式。制备过程和诊断和治疗用途。
• Ruthenium-Catalyzed Asymmetric Hydrogenation of <i>N</i>-Boc-Indoles
  作者：Ryoichi Kuwano、Manabu Kashiwabara

  DOI：10.1021/ol061039x

  日期：2006.6.1

  enantioselective hydrogenation of various N-Boc-indoles proceeded successfully in the presence of the ruthenium complex generated from an appropriate ruthenium precursor and a trans-chelate chiral bisphosphine PhTRAP. Various 2- or 3-substituted indoles were converted into chiral indolines with high enantiomeric excesses (up to 95% ee). The PhTRAP-ruthenium catalyst was able to promote the hydrogenation of 2,3-dimethylindoles

  在适当的钌前体和反式螯合手性双膦PhTRAP生成的钌络合物存在下，成功进行了各种N-Boc-吲哚的高度对映选择性氢化。各种2-或3-取代的吲哚被转化为具有高对映体过量（至多95％ee）的手性二氢吲哚。PhTRAP-钌催化剂能够促进2，3-二甲基吲哚的氢化，得到具有72％ee的顺式2,3-二甲基二氢吲哚。
• Iridium‐Catalyzed Enantioselective Hydrogenation of Indole and Benzofuran Derivatives
  作者：Yao Ge、Zheng Wang、Zhaobin Han、Kuiling Ding

  DOI：10.1002/chem.202002532

  日期：2020.12

  Enantioselective hydrogenation of a broad spectrum of N‐, O‐, and S‐containing aromatic benzoheterocycles or nonaromatic unsaturated heterocycles has been realized by using an Ir/SpinPHOX (SpinPHOX=spiro[4,4]‐1,6‐nonadiene‐based phosphine‐oxazoline) complex as the catalyst, affording an array of the corresponding chiral benzoheterocycles (30 examples) with excellent enantioselectivities (>99 % ee in

  通过使用Ir / SpinPHOX（SpinPHOX = spiro [4,4] -1,6-壬二烯基膦，已经实现了对N，O和S的各种芳族苯并杂环或非芳族不饱和杂环的对映选择性氢化） -恶唑啉）络合物作为催化剂，可提供一系列相应的手性苯并杂环化合物（30个实例），具有出色的对映选择性（大多数情况下> 99％  ee），周转数高达500。
• Aminooxazole Inhibitors of Cyclin Dependent Kinases
  申请人：Neosome Life Sciences, LLC

  公开号：US20130184288A1

  公开（公告）日：2013-07-18

  Oxazole derivatives are described. The inventive compounds are useful as kinase inhibitors, and may be used in the treatment of cancer, such as prostate cancer, lung cancer, breast cancer, colon cancer, leukemia, CNS cancer, melanoma, ovarian cancer, and renal cancer.

  本文描述了噁唑衍生物。这些创新的化合物可用作激酶抑制剂，并可用于治疗癌症，如前列腺癌，肺癌，乳腺癌，结肠癌，白血病，中枢神经系统癌症，黑色素瘤，卵巢癌和肾癌。
• Iridium-Catalyzed Asymmetric Hydrogenation of N-Protected Indoles
  作者：Alejandro Baeza、Andreas Pfaltz

  DOI：10.1002/chem.200903105

  日期：2010.2.15